Involvement of G-protein βγ subunits on the influence of inhibitory α2-autoreceptors on the angiotensin AT1-receptor modulation of noradrenaline release in the rat vas deferens

Neurochemistry International

Volumn 49, Issue 7, 2006, Pages 698-707

  Talaia, Carlos ^a   Queiroz, Glória ^a   Pinheiro, Helder ^a   Moura, Daniel ^b   Gonçalves, Jorge ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b University of Porto   (Portugal)

Author keywords

AT1 receptors; G subunits; Gi o coupled receptors; Noradrenaline release; Protein kinase C; Receptor crosstalk

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 2,5 PYRROLIDINEDIONE; 3 [8 [(DIMETHYLAMINO)METHYL] 6,7,8,9 TETRAHYDROPYRIDO[1,2 A]INDOL 10 YL] 4 (1 METHYL 1H INDOL 3 YL) 1H PYRROLE 2,5 DIONE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ALPHA 2 ADRENERGIC RECEPTOR; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN II; AUTORECEPTOR; BRIMONIDINE; DESIPRAMINE; GLYCOSAMINOGLYCAN; GUANINE NUCLEOTIDE BINDING PROTEIN BETA SUBUNIT; LOSARTAN; NORADRENALIN; PEPTIDE DERIVATIVE; PERTUSSIS TOXIN; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHATE; PHOSPHOLIPASE C; PROTEIN KINASE C; RECEPTOR SUBTYPE; TRITIUM; YOHIMBINE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ELECTROSTIMULATION; ENZYME ACTIVATION; MALE; NERVE STIMULATION; NEUROMODULATION; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; VAS DEFERENS;

ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN II; ANIMALS; AUTORECEPTORS; ELECTRIC STIMULATION; ENZYME INHIBITORS; GTP-BINDING PROTEIN BETA SUBUNITS; GTP-BINDING PROTEIN GAMMA SUBUNITS; MALE; NEURAL INHIBITION; NOREPINEPHRINE; PERTUSSIS TOXIN; PHOSPHOLIPASE C; PRESYNAPTIC TERMINALS; PROTEIN KINASE C; RATS; RATS, WISTAR; RECEPTOR CROSS-TALK; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, ADRENERGIC, ALPHA-2; SIGNAL TRANSDUCTION; SYMPATHETIC FIBERS, POSTGANGLIONIC; SYNAPTIC TRANSMISSION; TRITIUM; TYPE C PHOSPHOLIPASES; VAS DEFERENS;

PHOS;

EID: 33750019759     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2006.07.002     Document Type: Article

References (53)

1. Apparsundaram S., and Eikenburg D.C. Role of prejunctional beta adrenoceptors in rat cardiac sympathetic neurotransmission. J. Pharmacol. Exp. Ther. 272 (1995) 519-526
2. Banno Y., et al. Stimulation by G protein βγ subunits of phospholipase C beta isoforms in human platelets. Thromb. Haemost. 79 (1998) 1008-1013
3. Barrett C.F., and Rittenhouse A.R. Modulation of N-type calcium channel activity by G-proteins and protein kinase C. J. Gen. Physiol. 115 (2000) 277-286
4. 2+ entry. Science 292 (2001) 293-297
5. Blank J.L., et al. Activation of cytosolic phosphoinositide phospholipase C by G-protein βγ subunits. J. Biol. Chem. 267 (1992) 23069-23075
6. Boehm S., and Kubista H. Fine-tuning of sympathetic transmitter release via ionotropic and metabotropic presynaptic receptors. Pharmacol. Rev. 4 (2002) 43-99
7. 1-receptor mediated increase of noradrenaline release by angiotensin II is seen only in the presence of prejunctional autoinhibition. Adv. Exp. Med. Biol. 377 (1995) 293-298
8. Bylund D.B., and Ray-Prenger C. Alfa-2A and alfa-2B adrenergic receptor subtypes: attenuation of cyclic AMP production in cell lines containing only one receptor subtype. J. Pharmacol. Exp. Ther. 251 (1989) 640-644
9. Chang M., et al. Dissecting G protein-coupled receptor signaling pathways with membrane-permeable blocking peptides. J. Biol. Chem. 275 (2000) 7021-7029
10. Costa M., and Majewski H. Facilitation of noradrenaline release from sympathetic nerves through activation of ACTH receptors, β-adrenoceptors and angiotensin II receptors. Br. J. Pharmacol. 95 (1988) 993-1001
11. Cox S.L., et al. Evidence for the involvement of different receptor subtypes in the pre- and postjunctional actions of angiotensin II at rat sympathetic neuroeffector sites. Br. J. Pharmacol. 114 (1995) 1057-1063
12. i/o protein-coupled receptors. Br. J. Pharmacol. 129 (2000) 1095-1102
13. De Gasparo, et al. International Union of Pharmacology. XXIII. The angiotensin II receptors. Pharmacol. Rev. 52 (2000) 415-472
14. 2+ channels in rat sympathetic neurons. J. Physiol. 518 (1999) 23-36
15. Driessen B., et al. Opposite modulation of noradrenaline and ATP release in guinea-pig vas deferens through prejunctional beta-adrenoceptors: Evidence for the beta2 subtype. Naunyn-Schmied. Arch. Pharmacol. 353 (1996) 564-571
16. Duncia J.V., et al. The discovery of DuP 753, a potent orally active non-peptide angiotensin II receptor antagonist. Med. Res. Rev. 12 (1992) 149-191
17. 1-receptor agonists. Naunyn-Schmied. Arch. Pharmacol. 337 (1988) 477-483
18. 2-Adrenoceptors potentiate angiotensin II- and vasopressin-induced renal vasoconstriction in spontaneously hypertensive rats. J. Pharmacol. Exp. Ther. 305 (2003) 581-586
19. Gonçalves J., et al. Opposite modulation of cotransmitter release in guinea-pig vas deferens: increase of noradrenaline and decrease of ATP release by activation of prejunctional β-adrenoceptors. Naunyn-Schmied. Arch. Pharmacol. 353 (1996) 192-194
20. 1A postjunctionally. Cardiovasc. Res. 67 (2005) 208-215
21. Hamid J., et al. Identification of an integration center for cross talk between protein kinase C and G protein modulation of N-type calcium channels. J. Biol. Chem. 274 (1999) 6195-6202
22. Hur E.-M., and Kim K.-T. G protein-coupled receptor signalling and cross-talk achieving rapidity and specificity. Cell. Signal. 14 (2002) 397-405
23. 2-adrenoceptors and angiotensin II receptors in genetic hypertension. Hypertension 38 (2001) 353-360
24. Johnston H., and Majewski H. Prejunctional β-adrenoceptors in rabbit pulmonary artery and mouse atria: effect of α-adrenoceptor blockade and phosphodiesterase inhibition. Br. J. Pharmacol. 87 (1986) 553-562
25. Kaslow H.R., et al. Structure-activity of the activation of pertussis toxin. Biochemistry 26 (1987) 123-127
26. Kirpekar S.M., et al. Effect of tetraethylamonium and barium on the release of noradrenaline from perfused cat spleen by nerve stimulation and potassium. Naunyn-Schmied. Arch. Pharmacol. 294 (1976) 23-29
27. 2-adrenoceptor-mediated response. Eur. J. Pharmacol. 90 (1983) 453-456
28. Lee J.J., et al. Activation of protein kinase C antagonizes the opioid inhibition of calcium current in rat spinal dorsal horn neurons. Brain Res. 1017 (2004) 108-119
29. 2A-adrenergic receptor by protein kinase C. Mol. Pharmacol. 54 (1998) 44-49
30. Majewski H., and Rand M.J. An interaction between prejunctional α-adrenoceptors and prejunctional β-adrenoceptors. Eur. J. Pharmacol. 69 (1981) 493-498
31. 2-autoreceptor-stimulation on the facilitation by angiotensin II and bradykinin of noradrenaline release. Naunyn-Schmied. Arch. Pharmacol. 368 (2003) 443-447
32. 2-autoreceptors and prejunctional receptors mediating a facilitatory effect on noradrenaline release. Pharmacol. Res. 42 (2000) 383-388
33. i-2. Am. J. Physiol. Cell Physiol. 279 (2000) C925-C934
34. 1-receptor blockade and sympathetic neurotransmission in cardiovascular disease. Auton. Autacoid Pharmacol. 23 (2004) 285-296
35. Oh P., and Schnitzer J.E. Segregation of heterotrimeric G proteins in cell surface microdomains. Mol. Biol. Cell. 12 (2001) 685-698
36. Orr A.W., et al. Trombospondin stimulates focal adhesion disassembly through Gi- and phosphoinositide 3-kinase-dependent ERK activation. J. Biol. Chem. 277 (2002) 20453-20460
37. Pinheiro H., et al. A comparison of several AT1 angiotensin II antagonists at pre-and postjunctional angiotensin II receptors of the rat tail artery. Naunyn-Schmied. Arch. Pharmacol. 366 (2002) 537-542
38. 2B receptors involved in the facilitation of noradrenaline release in the prostatic portion of rat vas deferens. Neuropharmacology 47 (2004) 216-224
39. 2A receptor-mediated facilitation of noradrenaline release involves protein kinase C activation and attenuation of presynaptic inhibitory receptor-mediated effects in the rat vas deferens. J. Neurochem. 85 (2003) 740-748
40. Razani B., et al. Caveolae: from cell biology to animal physiology. Pharmacol. Rev. 54 (2002) 431-467
41. Selbie L.A., and Hill S.J. G protein-coupled-receptor crosstalk: the fine-tuning of multiple receptor-signaling pathways. Trends Pharmacol. Sci. 19 (1998) 87-93
42. Shoji-Kasai Y., et al. Protein kinase C-mediated translocation of secretory vesicles to plasma membrane and enhancement of neurotransmitter release from PC12 cells. Eur. J. Neurosci. 15 (2002) 1390-1394
43. Singer E.A. Transmitter release from brain slices elicited by single pulses: a powerful method to study presynaptic mechanisms. Trends Pharmacol. Sci. 9 (1988) 274-276
44. Starke K. Regulation of noradrenaline release by presynaptic receptor systems. Rev. Physiol. Biochem. Pharmacol. 77 (1977) 1-124
45. 2-adrenoceptors. J. Neurochem. 78 (2001) 685-693
46. Starke K., and Schümann H.J. Interactions of angiotensin, phenoxybenzamine and propanolol on noradrenaline release during sympathetic nerve stimulation. Eur. J. Pharmacol. 18 (1972) 27-30
47. Sum C.-S., et al. Potentiation of purinergic transmission by angiotensin in prostatic rat vas deferens. Br. J. Pharmacol. 118 (1996) 1523-1529
48. 2+ channels by protein kinase C in rat central and peripheral neurons: disruption of G protein-mediated inhibition. Neuron 11 (1993) 305-320
49. 2-adrenoceptors on the modulation of noradrenaline release in the rat vas deferens: possible involvement of a group 2 adenylyl cyclase isoform. Neurochem. Int. 47 (2005) 418-429
50. 2-adrenoceptor-deficient mice. Br. J. Pharmacol. 138 (2003) 1389-1402
51. von Kügelgen I., et al. Axon terminal P2-purinoceptors in feedback control of sympathetic transmitter release. Neuroscience 56 (1993) 263-267
52. Wilkinson S.E., et al. Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C. Biochem. J. 294 (1993) 335-337
53. 2A receptors of NMDA and AMPA currents in rat neostriatal neurons. Br. J. Pharmacol. 130 (2000) 259-269